查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946987

即时检测（POC​​T）全球市场报告（2026年）

Point-Of-Care-Testing (POCT) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，即时检测（POC​​T）市场规模快速扩张，预计将从2025年的507.9亿美元成长到2026年的566.8亿美元，复合年增长率（CAGR）为11.6%。过去几年的成长可归因于多种因素，例如慢性病盛行率上升、对快速临床决策的需求日益增长、急诊和重症监护服务的扩展、中心检查室资源有限以及对即时诊断结果的需求。

预计未来几年，即时检测（POC​​T）市场将快速成长，到2030年市场规模将达到869.1亿美元，复合年增长率（CAGR）为11.3%。预测期内的成长要素包括POCT设备小型化程度的不断提高、居家医疗和远端患者监护的普及、感染疾病疫情的增加、医疗保健的去中心化程度的提高以及自我检测的日益普及。预测期内的主要趋势包括：即时快速诊断检测的普及、对家庭和自我检测解决方案的需求不断增长、市售诊断产品的种类日益丰富、对疾病早期检测和筛检的日益重视以及POCT设备准确性和灵敏度的提高。

预计未来几年，远端医疗的日益普及将推动就地检验（POC​​T）市场的成长。远端医疗是指利用视讯通话、电话咨询和安全通讯等数位通讯技术远端提供医疗服务。尤其是在新冠疫情爆发后，由于人们对便利、及时和非接触式医疗服务的需求激增，远距医疗的普及速度显着加快。 POCT能够快速可靠地将诊断结果即时共用给远端医疗的发展。例如，根据美国医院协会（美国专业组织）2025年4月发布的报告，2023年超过12.6%的联邦医疗保险受益人使用了远端医疗服务。预计到2036年，美国医生数量将达到8.6万人，凸显了远端医疗在解决日益严重的医生短缺问题方面的重要角色。因此，远端医疗的日益普及正在推动POCT市场的成长。

为了满足基层医疗对更快速的临床级诊断和更有效的抗生素管理日益增长的需求，就地检验(POCT) 市场的主要企业正日益关注微流体快速抗菌药物敏感性测试 (AST) 系统等技术创新。微流体AST 技术利用微米级流体通道培养和检测尿液等患者检体中的细菌，其抗生素敏感性测定速度远快于通常需要数天的传统培养方法。例如，2023 年 6 月，日本诊断设备製造商 Sysmex 公司发布了 PA 100 AST 系统。这款紧凑型 POCT 分析仪采用 Sysmex Astrego 的专有微流体晶片，可在约 15 分钟内完成细菌检测，并在约 30 分钟内提供完整的 AST 结果。此系统操作极为简便。医护人员只需将检体放入一次性晶片，然后将其置于桌上型分析仪中，即可获得自动化的 AST 结果，无需接受专业的检查室培训。快速提供检测结果有助于在首次就诊时选择合适的抗生素，从而减少不恰当的处方，对抗抗菌素抗药性（AMR）。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球即时检测（POC​​T）市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
    • 生物技术、基因组学和精准医学
    • 工业4.0和智慧製造
  • 主要趋势
    • 提高即时诊断检测的普及率
    • 对家用和自测解决方案的需求日益增长
    • 扩大市售诊断产品的范围
    • 越来越重视疾病的早期检测和筛检
    • 提高即时检测设备的准确性和灵敏度

第五章 终端用户产业市场分析

  • 医院
  • 临床检查室
  • 门诊诊所和医生办公室
  • 居家照护和自我检测客户
  • 药局

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球即时检测（POC​​T）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球即时检测（POC​​T）市场规模、对比及成长率分析
  • 全球即时检测（POC​​T）市场表现：规模与成长，2020-2025年
  • 全球即时检测 (POCT) 市场预测：规模与成长，2025-2030 年，2035 年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 血糖检测、传染病检查、心臟标记检测、血液凝固检验、怀孕/不孕症检测、血液气体/电解质检测、尿液检查等。
  • 透过购买方式
  • 非处方药和处方笺药
  • 透过技术
  • 免疫检测、分子诊断、微生物检测、聚合酵素链锁反应(PCR) 检测、生物化学检验
  • 最终用户
  • 临床检查室、门诊护理机构和医生办公室、药房、零售诊所和电子商务平台、医院、重症监护中心、急诊中心、居家医疗和自我检测以及其他终端用户
  • 依类型细分：血糖检测
  • 自我监测血糖仪、连续血糖仪、瞬感血糖仪
  • 按类型细分：传染病检查
  • 人类免疫力缺乏病毒（HIV）检测、肝炎检测、流感检测、新冠病毒检测和其他传染病检查
  • 按类型细分：心臟标记检测
  • 肌钙蛋白检测、肌酸激酶-MB (CK-MB) 检测、肌红蛋白检测、B型钠尿肽 (BNP) 检测
  • 按类型细分：血液凝固检验
  • 凝血酶原时间 (PT) 检测、活化部份凝血活酵素时间(aPTT) 检测、国际标准化比值 (INR) 检测
  • 按类型细分：妊娠和生育力检测
  • 检测套组、排卵检测套组、生殖激素测试
  • 按类型细分：血气或电解质检测
  • 动脉血气分析、静脉血气分析、电解质检查
  • 按类型细分：尿液检查
  • 尿液化学分析、尿液显微镜检查及尿液培养
  • 按类型细分：其他类型
  • 药物滥用检测、过敏检测、胆固醇检测、甲状腺功能检测

第十章 区域与国家分析

  • 全球即时检测（POC​​T）市场：区域表现及预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球即时检测 (POCT) 市场：国家/地区、市场表现及预测，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 即时检测（POC​​T）市场：竞争格局与市场份额，2024年
  • 即时检测（POC​​T）市场：公司估值矩阵
  • 即时检测（POC​​T）市场：公司概况
    • Johnson & Johnson
    • F. Hoffmann-La Roche Ltd.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年即时检测（POC​​T）市场：提供新机会的国家
  • 2030年即时检测（POC​​T）市场：充满新机会的细分市场
  • 即时检测 (POCT) 市场 2030 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPOCT02_G26Q1

Point-of-care testing (POCT) refers to diagnostic testing conducted at or near the site of patient care, providing immediate results and enabling faster clinical decision-making. Its purpose is to deliver quick and accurate diagnostic information directly at the point of care, facilitating timely treatment and improved patient outcomes.

The primary types of point-of-care testing (POCT) include blood glucose testing, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, blood gas or electrolyte testing, urinalysis testing, and others. Blood glucose testing involves measuring the amount of sugar (glucose) in a person's blood to monitor and manage related conditions. POCT products are available through various purchase modes, including over-the-counter and prescription-based products, and utilize technologies such as immunoassays, molecular diagnostics, microbial detection, polymerase chain reaction (PCR) testing, and biochemical testing. Key end users include clinical laboratories, ambulatory care facilities, physician offices, pharmacies, retail clinics, e-commerce platforms, hospitals, critical care centers, urgent care centers, home care and self-testing, and others.

Tariffs have influenced the point-of-care testing market by increasing costs of imported diagnostic devices, reagents, and electronic components used in POCT systems. Segments such as molecular diagnostics, PCR testing, and immunoassay-based devices are most affected, particularly in Asia-Pacific and North America where cross-border trade of medical diagnostics is high. These cost pressures have impacted pricing and slowed adoption in cost-sensitive markets. However, tariffs have also encouraged local manufacturing, regional supply chain development, and innovation in cost-effective POCT solutions.

The point-of-care-testing (poct) market research report is one of a series of new reports from The Business Research Company that provides point-of-care-testing (poct) market statistics, including point-of-care-testing (poct) industry global market size, regional shares, competitors with a point-of-care-testing (poct) market share, detailed point-of-care-testing (poct) market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care-testing (poct) industry. This point-of-care-testing (poct) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care-testing (poct) market size has grown rapidly in recent years. It will grow from $50.79 billion in 2025 to $56.68 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing need for rapid clinical decision making, growth in emergency and critical care services, limited access to centralized laboratories, demand for immediate diagnostic results.

The point-of-care-testing (poct) market size is expected to see rapid growth in the next few years. It will grow to $86.91 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to advancement in poct device miniaturization, expansion of home care and remote patient monitoring, growing infectious disease outbreaks, increasing healthcare decentralization, rising adoption of self-testing diagnostics. Major trends in the forecast period include growing adoption of rapid diagnostic testing at point of care, rising demand for home-based and self-testing solutions, expansion of over-the-counter diagnostic products, increasing focus on early disease detection and screening, improved accuracy and sensitivity of poct devices.

The growing adoption of telemedicine is expected to drive the growth of the point-of-care testing (POCT) market in the coming years. Telemedicine involves delivering medical care remotely using digital communication technologies such as video calls, phone consultations, or secure messaging. Its adoption has accelerated due to rising demand for convenient, timely, and contact-free healthcare services, particularly following the COVID-19 pandemic. POCT supports telemedicine by providing rapid and reliable diagnostic results that can be shared instantly with remote healthcare providers, enabling timely clinical decisions. For example, in April 2025, the American Hospital Association, a U.S.-based professional organization, reported that in 2023, over 12.6% of Medicare beneficiaries utilized telehealth services. By 2036, the number of physicians is projected to reach 86,000, highlighting telehealth's crucial role in addressing the growing physician shortage. Consequently, the increasing adoption of telemedicine is fueling the growth of the POCT market.

Major companies in the point-of-care testing (POCT) market are increasingly emphasizing technological innovations, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to meet the growing demand for faster, clinic-level diagnostics and enhanced antimicrobial stewardship in primary care. Microfluidic AST technology uses micrometer-scale fluid channels to culture and detect bacteria from patient samples-such as urine-and determine their antibiotic susceptibility far more quickly than conventional culture-based methods, which typically take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA 100 AST System, a compact POCT analyzer that uses Sysmex Astrego's proprietary microfluidic cartridges to detect bacteria in roughly 15 minutes and deliver complete AST results in about 30 minutes. The system is highly user-friendly: healthcare professionals place the sample into a single-use cartridge, insert it into the desktop analyzer, and receive automated AST readouts without requiring specialized laboratory training. This rapid turnaround enables timely antibiotic decisions during the initial patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

In August 2024, Quest Diagnostics Inc., a US-based medical laboratory company, acquired LifeLabs LP for $1 billion (CAN $1.35 billion). This acquisition expands Quest Diagnostics' POCT offerings and strengthens access to innovative diagnostic solutions. LifeLabs LP is a Canada-based provider of point-of-care testing services.

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care-testing (poct) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care testing (POCT) market includes revenues earned by entities by providing services such as on-site diagnostic testing, rapid disease detection, mobile health screening, and patient self-testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care testing (POCT) market includes sales of portable HbA1c analyzers, handheld blood gas analyzers, CRP (C-reactive protein) test kits, multiplex respiratory pathogen detection kits, and lateral flow urine analysis devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care-Testing (POCT) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care-testing (poct) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care-testing (poct) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care-testing (poct) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Blood Glucose Testing; Infectious Diseases Testing; Cardiac Markers Testing; Coagulation Testing; Pregnancy And Fertility Testing; Blood Gas Or Electrolytes Testing; Urinalysis Testing; Other Types
  • 2) By Mode Of Purchase: Over-The-Counter Products; Prescribed Based Products
  • 3) By Technology: Immunoassays; Molecular Diagnostics; Microbial Detection; Polymerase Chain Reaction (PCR) Testing; Biochemical Testing
  • 4) By End-User: Clinical Laboratories; Ambulatory Care Facilities And Physician Offices; Pharmacies; Retail Clinics And E-Comm Platforms; Hospitals; Critical Care Centres; Urgent Care Centres; Home Care And Self-Testing; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices; Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices
  • 2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing; Hepatitis Testing; Influenza Testing; COVID-19 Testing; Other Infectious Diseases Testing
  • 3) By Cardiac Markers Testing: Troponin Testing; Creatine Kinase-MB (CK-MB) Testing; Myoglobin Testing; B-type Natriuretic Peptide (BNP) Testing
  • 4) By Coagulation Testing: Prothrombin Time (PT) Testing; Activated Partial Thromboplastin Time (aPTT) Testing; International Normalized Ratio (INR) Testing
  • 5) By Pregnancy And Fertility Testing: Pregnancy Test Kits; Ovulation Test Kits; Fertility Hormone Testing
  • 6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing; Venous Blood Gas Testing; Electrolyte Testing
  • 7) By Urinalysis Testing: Urine Chemistry Analysis; Microscopic Urine Analysis; Urine Culture Testing
  • 8) By Other Types: Drug Abuse Testing; Allergy Testing; Cholesterol Testing; Thyroid Function Testing
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; BioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; Nova Biomedical Corporation; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Trinity Biotech Plc; Sinocare Inc.; Menarini Diagnostics; Princeton BioMeditech; Helena Laboratories; Chembio Diagnostics; ARKRAY; Accriva; ACON Laboratories; Sekisui Diagnostics; PTS Diagnostics; Meridian Bioscience
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Point-Of-Care-Testing (POCT) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Point-Of-Care-Testing (POCT) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care-Testing (POCT) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Point-Of-Care-Testing (POCT) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Rapid Diagnostic Testing At Point Of Care
    • 4.2.2 Rising Demand For Home-Based And Self-Testing Solutions
    • 4.2.3 Expansion Of Over-The-Counter Diagnostic Products
    • 4.2.4 Increasing Focus On Early Disease Detection And Screening
    • 4.2.5 Improved Accuracy And Sensitivity Of Poct Devices

5. Point-Of-Care-Testing (POCT) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Ambulatory Care Facilities And Physician Offices
  • 5.4 Home Care And Self-Testing Users
  • 5.5 Pharmacies

6. Point-Of-Care-Testing (POCT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care-Testing (POCT) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Point-Of-Care-Testing (POCT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Point-Of-Care-Testing (POCT) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Point-Of-Care-Testing (POCT) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Point-Of-Care-Testing (POCT) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care-Testing (POCT) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care-Testing (POCT) Market Segmentation

  • 9.1. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types
  • 9.2. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Over-The-Counter Products, Prescribed Based Products
  • 9.3. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing
  • 9.4. Global Point-Of-Care-Testing (POCT) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users
  • 9.5. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Glucose Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices
  • 9.6. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Infectious Diseases Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing
  • 9.7. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Cardiac Markers Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing
  • 9.8. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing
  • 9.9. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Pregnancy And Fertility Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing
  • 9.10. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Gas Or Electrolytes Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing
  • 9.11. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Urinalysis Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing
  • 9.12. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

10. Point-Of-Care-Testing (POCT) Market Regional And Country Analysis

  • 10.1. Global Point-Of-Care-Testing (POCT) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Point-Of-Care-Testing (POCT) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care-Testing (POCT) Market

  • 11.1. Asia-Pacific Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care-Testing (POCT) Market

  • 12.1. China Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care-Testing (POCT) Market

  • 13.1. India Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care-Testing (POCT) Market

  • 14.1. Japan Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care-Testing (POCT) Market

  • 15.1. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care-Testing (POCT) Market

  • 16.1. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care-Testing (POCT) Market

  • 17.1. South Korea Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care-Testing (POCT) Market

  • 18.1. Taiwan Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care-Testing (POCT) Market

  • 19.1. South East Asia Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care-Testing (POCT) Market

  • 20.1. Western Europe Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care-Testing (POCT) Market

  • 21.1. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care-Testing (POCT) Market

  • 22.1. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care-Testing (POCT) Market

  • 23.1. France Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care-Testing (POCT) Market

  • 24.1. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care-Testing (POCT) Market

  • 25.1. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care-Testing (POCT) Market

  • 26.1. Eastern Europe Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care-Testing (POCT) Market

  • 27.1. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care-Testing (POCT) Market

  • 28.1. North America Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care-Testing (POCT) Market

  • 29.1. USA Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care-Testing (POCT) Market

  • 30.1. Canada Point-Of-Care-Testing (POCT) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care-Testing (POCT) Market

  • 31.1. South America Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care-Testing (POCT) Market

  • 32.1. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care-Testing (POCT) Market

  • 33.1. Middle East Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care-Testing (POCT) Market

  • 34.1. Africa Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care-Testing (POCT) Market Regulatory and Investment Landscape

36. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Company Profiles

  • 36.1. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Point-Of-Care-Testing (POCT) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Point-Of-Care-Testing (POCT) Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care-Testing (POCT) Market Other Major And Innovative Companies

  • Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY

38. Global Point-Of-Care-Testing (POCT) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care-Testing (POCT) Market

40. Point-Of-Care-Testing (POCT) Market High Potential Countries, Segments and Strategies

  • 40.1 Point-Of-Care-Testing (POCT) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Point-Of-Care-Testing (POCT) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Point-Of-Care-Testing (POCT) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer